Baum Larry, Ng Maggie C Y, So Wing-Yee, Lam Vincent K L, Wang Ying, Poon Emily, Tomlinson Brian, Cheng Suzanne, Lindpaintner Klaus, Chan Juliana C N
Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong.
Diabetes Care. 2005 Jul;28(7):1704-9. doi: 10.2337/diacare.28.7.1704.
Triglyceride-rich lipoprotein particles may promote the progression of diabetic nephropathy. Patients with diabetic nephropathy have increased plasma triglycerides and reduced activity of hepatic lipase (HL), which hydrolyzes triglycerides. We hypothesized that the HL -514C-->T polymorphism, which reduces HL expression, and its interactions with polymorphisms in apolipoprotein (apo) E and apoC3 increase the risk of diabetic nephropathy.
In a case-control study involving 374 Chinese type 2 diabetic patients with and 392 without diabetic nephropathy, we genotyped the HL -514C-->T, apoE exon 4, and apoC3 -482C-->T polymorphisms.
HL -514T-containing genotypes (T+) were associated with diabetic nephropathy (OR = 1.7, P = 0.0009). Adjustment by multiple logistic regression for hypertension, triglycerides, sex, non-HDL cholesterol, BMI, smoking, and alcohol intake did not diminish the association (OR = 1.8, P = 0.003). The association between HL T+ genotypes and diabetic nephropathy appeared stronger in diabetic patients with apoC3 -482 non-TT genotypes (OR = 1.9, P = 0.003) or apoE epsilon2 or epsilon4 alleles (OR = 2.2, P = 0.005). Subjects with HL TT exhibited trends toward increased triglyceride and non-HDL cholesterol levels compared with CC carriers.
HL T+ genotypes might increase the risk of developing diabetic nephropathy by slowing clearance of triglyceride-rich remnant lipoproteins. In concert with other risk factors (e.g., hyperglycemia), lipid abnormalities may damage the kidneys and endothelium, where reduced binding sites for lipases may precipitate a vicious cycle of dyslipidemia, proteinuria, and nephropathy.
富含甘油三酯的脂蛋白颗粒可能促进糖尿病肾病的进展。糖尿病肾病患者血浆甘油三酯升高,而水解甘油三酯的肝脂酶(HL)活性降低。我们推测,降低HL表达的HL -514C→T多态性及其与载脂蛋白(apo)E和apoC3多态性的相互作用会增加糖尿病肾病的风险。
在一项病例对照研究中,纳入了374例患有糖尿病肾病的中国2型糖尿病患者和392例无糖尿病肾病的患者,对HL -514C→T、apoE第4外显子和apoC3 -482C→T多态性进行基因分型。
含HL -514T的基因型(T+)与糖尿病肾病相关(比值比[OR]=1.7,P=0.0009)。通过多因素logistic回归对高血压、甘油三酯、性别、非高密度脂蛋白胆固醇、体重指数、吸烟和饮酒进行校正后,该关联并未减弱(OR=1.8,P=0.003)。在apoC3 -482非TT基因型(OR=1.9, P=0.003)或apoE ε2或ε4等位基因(OR=2.2, P=0.005)的糖尿病患者中,HL T+基因型与糖尿病肾病之间的关联似乎更强。与CC携带者相比,HL TT受试者的甘油三酯和非高密度脂蛋白胆固醇水平有升高趋势。
HL T+基因型可能通过减缓富含甘油三酯的残余脂蛋白的清除而增加发生糖尿病肾病的风险。与其他危险因素(如高血糖)共同作用时,脂质异常可能损害肾脏和内皮,而脂酶结合位点减少可能会引发血脂异常、蛋白尿和肾病的恶性循环。